Page last updated: 2024-10-28

ibudilast and Cancer of Gastrointestinal Tract

ibudilast has been researched along with Cancer of Gastrointestinal Tract in 1 studies

Research Excerpts

ExcerptRelevanceReference
" A population pharmacokinetic approach was used to determine oxaliplatin and 5-fluorouracil pharmacokinetics with and without ibudilast."2.94Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer. ( Blinman, PL; Dhillon, HM; Galettis, P; McLachlan, AJ; Proschogo, N; Reuter, SE; Teng, C; Vardy, JL, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Teng, C1
Reuter, SE1
Blinman, PL1
Dhillon, HM1
Galettis, P1
Proschogo, N1
McLachlan, AJ1
Vardy, JL1

Trials

1 trial available for ibudilast and Cancer of Gastrointestinal Tract

ArticleYear
Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer.
    Cancer chemotherapy and pharmacology, 2020, Volume: 86, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Female; Fluorouracil; Gastr

2020